ASSESSMENT OF SERUM SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) AS A POTENTIAL RISK MARKER IN OBESE WOMEN WITH PREDICTIVE MARKER FOR POLYCYSTIC OVARY SYNDROME. (2024). CAHIERS MAGELLANES-NS, 6(2), 4972-4983. http://cahiersmagellanes.com/index.php/CMN/article/view/782